Share on PinterestThe identification of a new protein in the blood could help detect Alzheimer’s before symptoms begin.A new study has found that a type of protein in the blood could help predict Alzheimer’s disease.The research, published in the Journal of Experimental Medicine, could allow experts to diagnose the condition decades before symptoms begin to…
Study: 2-layer cloth face masks work better Study: 2-layer cloth face masks work better 02:09 A new study of COVID-19, based on data from a symptom tracker app, determined that there are six distinct "types" of the disease involving different clusters of symptoms. The discovery could potentially open new possibilities for how doctors can better treat…
Summer weather has not stopped COVID-19 Summer weather has not stopped COVID-19 09:44 A new study of COVID-19, based on data from a symptom tracker app, determined that there are six distinct "types" of the disease involving different clusters of symptoms. The discovery could potentially open new possibilities for how doctors can better treat individual patients…
The Virginia Department of Health has reported the fifth confirmed case in the state of a pediatric inflammatory illness associated with COVID-19—and the first case of the condition in the Shenandoah Valley.The department’s website on Friday showed a new case of Multisystem Inflammatory Syndrome in Children in the Central Shenandoah Health District, which includes Augusta…
9Health Expert Dr. Payal Kohli answered our questions about a new study in The New England Journal of Medicine. DENVER, Colorado — For months now, doctors have known age plays a role in how people respond to COVID-19. Health conditions like heart disease and diabetes can also impact the severity of the infection. But a…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.